Inactive Instrument

News Chelsea Therapeutics International Ltd.

Equities

US1634281059

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	14-06-12	GL
Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	14-05-09	BU
Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	14-05-08	BU
Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day	14-02-28	GL
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA™ (Droxidopa) for the Treatment of Symptomatic NOH	14-02-18	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA? (Droxidopa) for the Treatment of Symptomatic NOH	14-02-18	BU
Chelsea Therapeutics Names Keith W. Schmidt Chief Commercial Officer	14-01-30	GL
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director	14-01-27	GL
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH	13-12-09	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Completes Public Offering of Common Stock	13-11-18	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces Public Offering of Common Stock	13-11-12	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Reports Third Quarter 2013 Financial Results	13-11-05	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Advisory Committee to Review NORTHERA(TM) (droxidopa)	13-10-09	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference	13-09-19	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission	13-09-04	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces Submission of Additional Information for NORTHERA(TM) (Droxidopa) NDA	13-08-14	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics to Present at the 2013 Wedbush Life Sciences Management Access Conference	13-08-07	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Reports Second Quarter 2013 Financial Results	13-08-06	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces Update to NORTHERA(TM) (Droxidopa) NDA Filing	13-07-29	PU
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission	13-07-17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chelsea Therapeutics International Ltd.

Equities

US1634281059

Summary

Filters